TELA Bio (TELA) Cash & Equivalents (2018 - 2026)
TELA Bio (TELA) posted quarterly Cash & Equivalents of $39.5 million for Q1 2026, down 7.69% year-over-year from $42.8 million in Q1 2025, and down 22.23% quarter-over-quarter from $50.8 million in Q4 2025.
TELA Bio (TELA) Cash & Equivalents (2018 - 2026) Analysis & Trends
TELA Bio's Cash & Equivalents history runs 9 years deep, the most recent figure standing at $39.5 million for Q1 2026.
- In Q1 2026, Cash & Equivalents fell 7.69% year-over-year to $39.5 million; the TTM figure through Mar 2026 stood at $39.5 million (down 7.69% YoY), while the FY2025 annual figure was $50.8 million, down 3.46% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $39.5 million, down from $50.8 million in the prior quarter.
- The five-year high for Cash & Equivalents was $65.3 million in Q2 2023, with the low at $17.3 million in Q3 2024.
- The 5-year median for Cash & Equivalents is $39.5 million (2026), against an average of $40.5 million.
- The sharpest annual moves came in 2023 and 2024: Cash & Equivalents surged 135.4% in 2023, then sank 70.27% in 2024.
- TELA Bio's Cash & Equivalents stood at $42.0 million in 2022, then rose by 11.21% to $46.7 million in 2023, then increased by 12.71% to $52.7 million in 2024, then dropped by 3.46% to $50.8 million in 2025, then slipped by 22.23% to $39.5 million in 2026.
- Business Quant data shows TELA's Cash & Equivalents at $39.5 million in Q1 2026, $50.8 million in Q4 2025, and $29.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 482.30 Mn |
| 10 | TELA Bio | 36.75 Mn | 6.32 Mn | 13.94 Mn | 30.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.42 Mn |
| Mar 31, 2026 | 39.54 Mn |
| Dec 31, 2025 | 50.85 Mn |
| Sep 30, 2025 | 29.71 Mn |
| Jun 30, 2025 | 34.98 Mn |
| Mar 31, 2025 | 42.83 Mn |
| Dec 31, 2024 | 52.67 Mn |
| Sep 30, 2024 | 17.30 Mn |
| Jun 30, 2024 | 26.50 Mn |
| Mar 31, 2024 | 37.14 Mn |
| Dec 31, 2023 | 46.73 Mn |
| Sep 30, 2023 | 58.20 Mn |
| Jun 30, 2023 | 65.27 Mn |
| Mar 31, 2023 | 30.12 Mn |
| Dec 31, 2022 | 42.02 Mn |
| Sep 30, 2022 | 54.23 Mn |
| Jun 30, 2022 | 27.73 Mn |
| Mar 31, 2022 | 33.02 Mn |
| Dec 31, 2021 | 43.93 Mn |
| Sep 30, 2021 | 53.64 Mn |